Naveed Shams, M.D., Ph.D. Senior Corporate Officer, CSO, Head of Global Research & Development Motoo Sakurai Corporate Communications Group, IR Team, Team Manager PLAY LIST from the beginning Q1 FY2018 Earnings Conference Call Santen’s Values and Mission Statement MTP2020 Fundamental Policy and Strategic Goals Q1 FY2018 Financial Results ended June 30, 2018 Q1 FY2018 Financial Overview Q1 FY2018 Revenue Q1 FY2018 Core Operating Profit Performance by Business (Japan) Performance by Business (Asia) Performance by Business (EMEA) FY2018 Forecast (No change from May 9) Dividend Forecast for FY2018 (No change from May 9) Status of Research & Development Pipeline / Product Development Status (1) Pipeline / Product Development Status (2) Appendix Q1 FY2018 Profit and Loss Statement Q1 FY2018 Financial Position Q1 FY2018 Segment Revenue Capital Expenditures / Depreciation & Amortization Prescription Ophthalmic Market in Japan Forward-Looking Statements @ Q&A Q&A 1 Q&A 2 Q&A 3 Q&A 4 Q&A 5 Q&A 6 Q&A 7 Back Next